Received Apr 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 3 | Y006393 | IM / RA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y017206 | SC / RA |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 4 | LG5574 | IM / LL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y015101 | SC / LA |
Patient received both Proquad and Varivax vaccine during 12 month well child exam visit on 3/18/2025. Multiple attempts have been made to contact parents to follow-up on child's health status and ensure child had not developed any adverse effects post vaccinations. Clinical team was unsuccessful in contacting the parents despite making several attempts. Child has a scheduled appointment on June 26, 2025 for a 15 month old well child exam and team will ensure to obtain correct contact information as well as confirm if child had any adverse effects.
None
None
None
No known drug Allergies
unknown